Browse by Title

Type here to filter the list

O
One talk providing overview of IGV and a few short examples on the screen

Mark Routbort, MD, PhD (he/him/his) – MD Anderson Medical Center ### 2617450###Breakout Speaker###Professor###MD Anderson Medical Center###
Breakout Speaker: Mark Routbort, MD, PhD (he/him/his) – MD Anderson Medical Center
### he/him/his
Opportunities and challenges with implementing ACMG secondary findings

David T Miller, MD, PhD (he/him/his) – Boston Children's Hospital ### 2617430###Breakout Speaker###Medical Geneticist###Boston Children's Hospital###
Breakout Speaker: David T Miller, MD, PhD (he/him/his) – Boston Children's Hospital
### he/him/his
Opportunities and challenges with implementing polygenic risk score testing to assess common disease risks

Peter O`Donnell ### 2639499###Breakout Speaker#########
Breakout Speaker: Peter O`Donnell
###
Optimizing Diagnostic Stewardship: Clinician and Lab Director Perspectives on Effective Test Utilization

Anisha Misra, n/a (she/her/hers) – Cleveland Clinic-Lerner Research Institute ### 2391701###Program Committee Moderator###Medical director for Mycology and Parasitology###Cleveland Clinic-Lerner Research Institute###
Program Committee Moderator: Anisha Misra, n/a (she/her/hers) – Cleveland Clinic-Lerner Research Institute
### she/her/hers
Optimizing Diagnostic Stewardship: Clinician and Lab Director Perspectives on Effective Test Utilization

Daniel Morgan (he/him/his) – University of Maryland ### 2617418###Breakout Speaker######University of Maryland###
Breakout Speaker: Daniel Morgan (he/him/his) – University of Maryland
### he/him/his
Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities

Amir Behdad, n/a – Cleveland Clinic Florida ### 2277482###Program Committee Moderator###Professor and Regional Chair of Pathology###Cleveland Clinic Florida###
Program Committee Moderator: Amir Behdad, n/a – Cleveland Clinic Florida
###
Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities (Panel discussion)

Annette S. Kim, MD, PhD (she/her/hers) – University of Michigan ### 2520113###Breakout Speaker###Henry Clay Bryant Professor of Pathology, Director of Diagnostic Genetics and Genomics###University of Michigan###
Breakout Speaker: Annette S. Kim, MD, PhD (she/her/hers) – University of Michigan
### she/her/hers